Actualités dans la gestion des syndromes coronariens aigus

More documents

Recommendations

Info

96-Hour Primary Efficacy Results Routine Early Eptifibatide (n=4722) Delayed Provisional Eptifibatide (n=4684) OR (95% CI) Death, MI, RIUR, TBO 9.3% 10.0% 0.92 0.23 (0.80-1.06) Death 0.8% 0.9% 0.96 0.87 (0.62-1.50) Death or MI 7.5% 8.3% 0.89 0.13 (0.77-1.04) Death, MI, RIUR 8.4% 9.4% 0.89 0.11 (0.77-1.03 ) MI, myocardial infarction; RIUR, recurrent ischemia requiring urgent revascularization; TBO, thrombotic bailout EARLY ACS NEJM 2009 P
Small Molecule GP IIb/IIIa Inhibition in NSTE ACS PURSUIT PRISM PRISM PLUS Theroux PARAGON B PARAGON A 0.88 (0.79-0.97) COMBINED 1998 (n = 23,967) ACUITY Timing EARLY ACS 0.92 (0.82-1.01) 0.89 (0.84-0.95) EARLY ACS + ACUITY COMBINED 2009 (n = 42,666) 0.25 0.50 1.0 2.0 4.0 Odds Ratio for 30-day Death or MI Relative to Control
Page 1 and 2: Actualités s 2010 pour la prise en
Page 3 and 4: douleur thoracique douleur persista
Page 5 and 6: Recommandations Européennes (ESC 2
Page 7 and 8: Le seul objectif du traitement de l
Page 9 and 10: Reperfusion Therapy: Important Time
Page 11 and 12: Stratégie de reperfusion d’un SC
Page 13 and 14: Angiography after Fibrinolytic Ther
Page 15 and 16: Fibrinolytic Therapy: Antithromboti
Page 17 and 18: Thrombolysis vs primary PCI : 1 Yr
Page 19 and 20: Peut on améliorer les délais % d
Page 21 and 22: Décès, FV, choc cardiogénique à
Page 23 and 24: Clopidogrel response variability fo
Page 25 and 26: 15 TRITON study : Primary Endpoint
Page 27 and 28: * Range ±7 7 days 3602 pts with ST
Page 29: 1-Year Death or Reinfarction Death
Page 32 and 33: CK release during reperfusion CK re
Page 34 and 35: Recommandations Européennes (ESC 2
Page 36 and 37: Critères pour le bilan coronarogra
Page 38 and 39: ACUITY - Primary Results UFH/Enoxap
Page 42 and 43: ABOARD : Individual Ischemic Endpoi

Actualités dans la gestion des syndromes coronariens aigus

Create successful ePaper yourself

Delete template?

Save as template?